Phathom Pharmaceuticals I...

NASDAQ: PHAT · Real-Time Price · USD
10.26
-0.21 (-2.01%)
At close: Aug 15, 2025, 3:59 PM
10.24
-0.15%
After-hours: Aug 15, 2025, 06:01 PM EDT

Phathom Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-330.15M -345.79M -334.33M -339.44M -297.11M -246.63M -201.59M -177.07M -184.92M -194.87M -197.72M -178.5M -164.07M -149.71M -143.88M -161.78M -159.22M -143.77M
Depreciation & Amortization
733K 758K 795K 787K 717K 643K 575K 558K 612K 638K 620K 587K 542K 524K 521K 492K 450K 396K
Stock-Based Compensation
26.13M 23.96M 24.05M 41.94M 42.45M 43.6M 45.02M 27.1M 26.77M 25.41M 24.13M 21.81M 20.42M 18.77M 16.81M 14.85M 12.5M 9.1M
Other Working Capital
7.92M 5.34M -1.95M 5.08M -7.56M -3.4M -9.09M -14.17M -6.37M -8.26M -9.45M -17.12M -20.8M -13.84M -17.68M 10.69M 13.9M 11.13M
Other Non-Cash Items
29.99M 44.94M 70.01M 67.19M 66.14M 53.51M 32.06M 29.05M 28.96M 26.34M 21M 15.15M 10.46M 6.64M 5.41M 4.47M 2.29M 2.12M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-1.39M -2.02M -9.04M 676K -9.38M -4.33M -13.64M -14.11M -9.01M 1.4M 5.44M -6.31M -8.65M -20.19M -27.48M 6.57M 16.92M 24.13M
Operating Cash Flow
-274.69M -282.68M -266.77M -247.11M -215.45M -166.93M -137.58M -134.48M -137.58M -141.1M -146.53M -147.26M -141.31M -143.95M -148.62M -135.4M -127.06M -108.04M
Capital Expenditures
81K 35K -5K -475K -1.5M -1.46M -1.63M -1.57M -766K -1.19M -1.04M -729K -609K -226K -328K -352K -521K -533K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-245K -148K -177K -1.83M -1.7M -1.7M -1.65M -1.18M -1.18M -1.18M -1.37M -517K -517K -517K -520K -1.38M -1.38M -1.38M
Investing Cash Flow
-164K -113K -135K -605K -1.5M -1.46M -1.63M -1.57M -766K -1.19M -1.04M -729K -609K -226K -328K -352K -521K -533K
Debt Repayment
24.75M 49.5M 59.4M 34.65M 34.65M 9.9M n/a n/a n/a n/a n/a n/a 42.76M 42.76M 42.76M 42.76M n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
1.66M 1.6M 1.6M 212.3M 212.03M 212.12M 212.12M -24.47M -24.48M 70.85M 70.85M 95.61M 96.87M 1.53M 1.94M 2.41M 1.15M 1.04M
Financial Cash Flow
148.18M 172.87M 182.77M 368.72M 246.68M 363.41M 367.58M 155.59M 180.17M 134.11M 120.04M 120.2M 139.64M 44.3M 44.71M 134M 89.97M 89.87M
Net Cash Flow
-126.67M -109.92M -84.13M 121M 29.73M 195.01M 228.37M 19.7M 41.98M -8.01M -27.37M -27.78M -2.28M -99.88M -104.24M -1.74M -37.6M -18.7M
Free Cash Flow
-274.63M -282.66M -266.77M -247.59M -216.95M -168.39M -139.21M -136.05M -138.35M -142.28M -147.57M -147.99M -141.91M -144.18M -148.94M -135.75M -127.58M -108.57M